A cross-sectional study of physiologic volar melanotic macules: Demographic, historical, clinical, and dermatoscopic features of a common yet neglected pigmentary variant in individuals with skin of color
A randomized phase III study to compare efficacy and safety of BAT2206 (proposed ustekinumab biosimilar) with reference ustekinumab in patients with moderate to severe plaque psoriasis
Race and appointment availability influence continuity of care for chronic inflammatory skin disease: A cross-sectional study of United States practice data
A genome-wide association meta-analysis links hidradenitis suppurativa to common and rare sequence variants causing disruption of the Notch and Wnt/β-catenin signaling pathways
Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study
Oncologic outcomes for invasive squamous cell carcinoma with a clinically resolved biopsy site managed by watchful waiting: A retrospective cohort study
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial
Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the diagnosis of allergic contact dermatitis: A series of 170 clinically- and patch test-confirmed cases
Nonsteroidal immune-modulating therapies and reduced risk of adverse cardiovascular events in dermatomyositis and polymyositis: A cohort study in the All of Us research program
Gabapentin improves the flushing of rosacea, but not other rosacea symptoms or quality of life: Results from a multicenter, randomized, double-blind, placebo-controlled pilot study
Risk of Candida and overall fungal infections with interleukin-17 inhibitors in the treatment of hidradenitis suppurativa: A systematic review and meta-analysis
JAAD Game Changers: Dilution of a mepivacaine-adrenaline solution in isotonic sodium bicarbonate for reducing subcutaneous infiltration pain in ambulatory phlebectomy procedures: A randomized, double-blind, controlled trial
Response to Wilson et al, “Geospatial assessment of American Indian/Alaskan Native access to dermatologists: Distances and travel times from reservations�
Response to Watters et al., “Educational intervention targeting primary care residents improves skin cancer recognition in patients with skin of color�
Regarding response to Watters et al’s “Educational intervention targeting primary care residents improves skin cancer recognition in patients with skin of color�
Comment on “Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's adverse event reporting system dataset�
Response to Chen et al’s “Emergence of Janus kinase inhibitors led to increase in proportion of severe alopecia areata patients receiving treatment: A retrospective cohort study�